0
Acura Pharmaceuticals, Inc. Banner Image

Acura Pharmaceuticals, Inc.

  • Ticker ACUR
    Exchange NASDAQ More
  • Industry Drug Delivery More
  • Sector Healthcare More
Acura Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Palatine, Illinois
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. The Company’s product, Oxecta Tablets CII (Oxecta) represents the immediate-release oxycodone product approved by the United States Food and Drug AdministrationMore that applies its Aversion Technology. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and capsules designed to address some common methods of product tampering associated with abuse. As of December 31, 2011, the Company was also developing Nexafed, an over-the-counter (OTC) immediate-release pseudoephedrine HCl tablet, utilizing its Impede Technology. On January 23, 2012, Oxecta was made commercially available by Pfizer Inc. (Pfizer). On June 17, 2011, Oxecta was approved for marketing by the United States Food and Drug Administration.
Acura Pharmaceuticals, Inc.

Most Recent Annual Report

Acura Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Acura Pharmaceuticals, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports